Allelic imbalance at the HER2/TOP2A locus in breast cancer

BACKGROUND: Breast cancer is a heterogeneous disease with various histological features and molecular markers. These are utilized for the prediction of clinical outcome and therapeutic decision making. In addition to well established markers such as HER2 overexpression and estrogen and progesterone...

Descripción completa

Detalles Bibliográficos
Autores principales: Huijsmans, Cornelis J. J., van den Brule, Adriaan J. C., Rigter, Henny, Poodt, Jeroen, van der Linden, Johannes C., Savelkoul, Paul H. M., Hilbink, Mirrian, Hermans, Mirjam H. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448206/
https://www.ncbi.nlm.nih.gov/pubmed/26022247
http://dx.doi.org/10.1186/s13000-015-0289-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4448206/
https://www.ncbi.nlm.nih.gov/pubmed/26022247
http://dx.doi.org/10.1186/s13000-015-0289-x

Ejemplares similares